Biotech Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors December 18, 2023
Biotech GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) December 18, 2023
Biotech Transcenta Announces the Publication of Preclinical Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate as Potential Novel Treatment Option for Metastatic Gastric Cancer in the European Journal of Nuclear Medicine and Molecular Imaging December 13, 2023
Biotech Live from ASH 2023 | Results from Chinese Studies of Olverembatinib Presented in Oral Report at the ASH Annual Meeting for the Sixth Consecutive Year, Including Data Showing Promising Efficacy in Patients with TKI-Resistant and/or Intolerant CML-CP December 13, 2023
Biotech Biocomposites exceeds revenue expectations and takes a big step forward in its research and development December 13, 2023
Biotech Dizal Impresses with Its Differentiated Hematological Oncology Portfolio at 2023 ASH December 12, 2023
Biotech Astraveus appoints Dr. Lars Henrik Peeck as Chief Business Development Officer December 12, 2023
Biotech Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients December 1, 2023
Search
Biotech
![Transcenta Announces the Publication of Preclinical Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate as Potential Novel Treatment Option for Metastatic Gastric Cancer in the European Journal of Nuclear Medicine and Molecular Imaging](https://pressreach.com/wp-content/uploads/2023/12/Biotech_Megapixl11_Foxaon)
December 13, 2023
December 13, 2023
December 13, 2023
December 12, 2023
December 12, 2023
December 12, 2023
December 1, 2023
December 1, 2023
